Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68084-698

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68084-698). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150 mg Blister

Label for Venlafaxine Hydrochloride extended-release capsules USP, 150 mg strength, manufactured by American Health Packaging. The label includes the drug name, dosage form, strength, lot number 123456, and expiration date 03/17, arranged in multiple identical smaller labels with barcodes.*

FDA Label Image

150 mg Carton

Packaging label for Venlafaxine Hydrochloride Extended-Release Capsules USP 150 mg by American Health Packaging. The label specifies a bottle of 100 capsules (10 x 10) for oral use. It includes the NDC number 68084-713-01, barcode, pharmacist instructions, storage conditions, and safety warnings, including dispensing with a medication guide and protection against broken blister packs.*

FDA Label Image

37.5 mg Blister

This image displays multiple identical labels for Venlafaxine Hydrochloride Extended-Release Capsules USP, each with a strength of 37.5 mg. The label includes the product name, dosage form, strength, a barcode, and the labeler information as American Health Packaging, Columbus, Ohio.*

FDA Label Image

37.5 mg Carton

Label for Venlafaxine Hydrochloride extended-release capsules USP, 37.5 mg strength, packaged as 100 capsules (10 x 10). The label includes National Drug Code (NDC) 68084-698-01 and states the product is for prescription use only. Distributed by American Health Packaging in Columbus, Ohio. Additional usage and storage information is provided in smaller text.*

FDA Label Image

75 mg Blister

Packaging label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg by American Health Packaging. The label includes multiple barcode sections, NDC number (00368-0840-79), expiration and lot number fields, and the manufacturer's location in Columbus, Ohio.*

FDA Label Image

75 mg Carton

Venlafaxine Hydrochloride Extended-Release Capsules USP 75 mg oral capsules in a package of 100 capsules (10x10). The label includes National Drug Code (NDC) 68084-709-01 and instructions for pharmacists to dispense a medication guide. Manufacturer and distributor listed as American Health Packaging, Columbus, Ohio.*

FDA Label Image

Ahp69801

Venlafaxine Hydrochloride 75 mg extended-release capsule, showing a two-tone capsule with one half gray and the other half white. The gray half is imprinted with the letter 'E' and the white half with the number '73' in black. The capsule is shown against a background with a millimeter scale for size reference.*

FDA Label Image

Ahp70901

Venlafaxine Hydrochloride extended release oral capsule imprinted with the code 'E 74'. The capsule is opaque, white in color, and capsule-shaped with no other markings visible. The image shows both sides of the capsule against a measurement grid background.*

FDA Label Image

Ahp71301

Venlafaxine Hydrochloride 75 mg extended-release oral capsules, red in color, imprinted with 'E 89' on one side. Image shows two capsules with one side displaying the imprint and the other side plain red. Labeler is American Health Packaging.*

FDA Label Image

Figure 1

A chart depicting pharmacokinetic (PK) fold changes and 90% confidence interval (CI) recommendations for Venlafaxine Hydrochloride when interacted with various drugs including Ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium. The chart compares parameters like Cmax and AUC for venlafaxine and its O-desmethylvenlafaxine (ODV) metabolite, providing recommendations such as dose adjustment or caution based on the interaction.*

FDA Label Image

Figure 2

A pharmacokinetic interaction chart depicting the fold changes in maximum concentration (Cmax) and area under the curve (AUC) for various interacting drugs with Venlafaxine Hydrochloride. The chart includes multiple drugs such as ethanol, diazepam, alprazolam, and others, along with recommendations regarding dose adjustment or caution. The x-axis shows the change relative to the reference value, ranging from 0 to 3.*

FDA Label Image

Figure 3

A scientific chart depicting the pharmacokinetic changes of venlafaxine in special populations such as hepatic (cirrhosis, mild and moderate impairment), renal (mild/moderate impairment and hemodialysis), CYP2D6 polymorphism, age over 60, and gender. The chart shows fold changes and 90% confidence intervals in Cmax, AUC, and ODV for venlafaxine, alongside dosing recommendations based on these changes.*

FDA Label Image

Structure

Chemical structure of venlafaxine hydrochloride showing its molecular composition and bonding arrangement. The diagram includes the characteristic cyclohexanol ring and methoxy-substituted phenyl group, labeled with relevant atomic groups and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.